
Fernando Gibran-Nunes, MD, highlights findings from a meta-analysis investigating the efficacy and safety of loncastuximab tesirine in pretreated DLBCL.

Your AI-Trained Oncology Knowledge Connection!


Fernando Gibran-Nunes, MD, is a hematologist at Hospital Sirio Libanês in São Paulo, Brazil.

Fernando Gibran-Nunes, MD, highlights findings from a meta-analysis investigating the efficacy and safety of loncastuximab tesirine in pretreated DLBCL.